Report Overview

Increasing preference for minimally invasive surgery, growing hospital investments in endoscopy instruments, and growing adoption of automated reprocessed endoscopes could boost the growth of United States endoscope reprocessing market during the forecast period between 2023 and 2029.

United States Endoscope Reprocessing Market - Industry Trends & Forecast Report, 2029

United States endoscope reprocessing market size was estimated at USD 1.99 billion in 2022. During the forecast period between 2023 and 2029, United States endoscope reprocessing market size is projected to grow at a CAGR of 8.62% reaching a value of USD 3.53 billion by 2029. Major growth drivers for United States endoscope reprocessing market include the rising number of endoscopy-related infections, rising hospital investments in endoscopy instruments, and rising number of diseases requiring endoscopy procedures. Endoscopic devices are being used more frequently in disease diagnosis and treatment. The rising prevalence of respiratory diseases such as lung cancer and chronic obstructive pulmonary disease is driving the market's expansion during the forecast period.

United States Endoscope Reprocessing Market - Overview

Endoscopy devices and their accessories must be thoroughly cleaned, disinfected, and sterilized as part of a multi-step process called "reprocessing" The demand for reprocessing equipment is primarily driven by the significant risk of infections associated with improper sterilization of endoscopes. The demand for sterilized and disinfected medical devices in hospitals and clinics, as well as a focus on strict cleaning standards, will propel the growth of the endoscope reprocessing industry.

Growth Drivers

Increasing Incidences of Diseases in Digestive System

Endoscopic examinations have increased due to the increased prevalence of digestive diseases as a result of changing lifestyles, boosting the market. The rising prevalence of launching innovative products for patient safety will generate new opportunities that will impact the endoscope reprocessing market growth during the forecast period of 2029. Advanced Sterilization Products (ASP) received 510(k) clearance for their ASP AEROFLEX AER automatic endoscope reprocessor in April. With a cycling time of 22 minutes, it is the quickest. As a new product, it will result in increased revenue and product portfolio expansion.

More Advanced Endoscopic Devices

The number of disorders requiring endoscopic procedures is increasing, endoscopy-related infections are becoming more common, hospitals are investing more money in endoscopy equipment, and endoscope reprocessing is becoming more and more popular. Endoscopic devices are increasingly used in disease diagnosis and treatment. The demand for these devices has increased due to the rising prevalence of disorders that can be detected by endoscopy.

Restraints

High Cost of endoscopy and Reprocessing equipment

Endoscopy's high cost reduces the number of endoscopic procedures performed on patients. Endoscopies, for example, can be expensive without insurance. A colonoscopy typically costs between USD 1,250 and USD 4,800 in the United States, while an endoscopy costs USD 2,750 on average. Furthermore, the equipment costs between USD 114.07 and USD 280.71. The average reported repair cost - whether due to a leak test failure, visual inspection damage, or a failed cleaning verification test - was estimated to be USD 5,833. The adoption of re-processing equipment may be hampered by such high prices.

Impact of COVID-19 on United States Endoscope Reprocessing Market

Automated endoscope reprocessors are now more crucial than ever because they were a crucial part of endoscopic surgery preparations during the COVID-19 pandemic when sterilization was a top priority. They have consequently gained popularity in hospitals and clinics. Due to their many benefits, Class II devices and automated endoscope reprocessors were in high demand. Additionally, the US Food and Drug Administration (US FDA) continued to approve brand-new automated endoscope reprocessors. For instance, Cantel Medical announced the 510(k) clearance for its ground-breaking automated endoscope preprocessor. Al these factors are expected to drive the US endoscopic reprocessing market at a significant rate during the forecast period.

United States Endoscope Reprocessing Market

Segmental Coverage

United States Endoscope Reprocessing Market - By Product

United States endoscope reprocessing market is divided into Equipment and Consumables segments.

United States Endoscope Reprocessing Market - By Modality

On basis of modality, United States endoscope reprocessing market is split into Bench Top Endoscopic Reprocessors, Stand-Alone Endoscopic Reprocessors segments.

United States Endoscope Reprocessing Market - By Process Type

On basis of process type, the United States endoscope reprocessing market is divided into Automated Cleaning Disinfectants, and Manual Cleaning Solutions segments. The automated cleaning disinfectants segment dominates the market. Endoscope reprocessors are automated machines that kill microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to high-level disinfectant or liquid chemical sterilant solutions. In addition, the use of automated endoscope reprocessors recommended in various guidelines is expected to contribute to the growth of the studied segment. Similarly, rising product launches and approvals, owing to the enhanced features of automated endoscope reprocessors, are expected to propel the studied segment during the forecast period.

United States Endoscope Reprocessing Market - By End User

On basis of end user, United States endoscope reprocessing market is divided into Hospitals, Ambulatory Surgical Centers (ASCS), Clinics, Diagnostic Centers, and other segments. The hospital segment holds the highest market share. This can be ascribed to an increase in the number of endoscopic procedures, an increase in the number of hospitals across the US, and the dissemination of funding and investments provided by government agencies.

Competitive Landscape

The competition in the United States endoscope reprocessing market is intense. Major players in the market include Cantel Medical, Ecolab, CONMED Corporation, Custom Ultrasonics.com, Micro-Scientific, LLC, Summit Imaging, Inc., Olympus Corporation, STERIS, Getinge AB, Wassenburg Medical, and Other Prominent Players. The key strategies used by these market leaders are new product launches, mergers & acquisitions, and alliances. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.

Recent Developments

• In February 2020 - Olympus Corporation of the Americas and Amplifire teamed up to offer technicians a new digital learning platform to learn about endoscope reprocessing. The Olympus TJF-Q180V duodenoscope, a complicated medical endoscope used for endoscopic retrograde cholangiopancreatography, will be reprocessed by the new digital learning platform (ERCP).

• In January 2020 - In the US, PENTAX Medical introduced the DEC HD Duodenoscope, an improved, high-definition duodenoscope with various disposable components for unit reprocessing, including the sterile distal cap and elevator lever.

Scope of the Report

By Products

• Equipment

• Consumables

By Modality

• Bench Top Endoscopic Reprocessors

• Stand-Alone Endoscopic Reprocessors

By Process Type

• Automated Cleaning Disinfectants

• Manual Cleaning Solutions

End User

• • Hospitals

  • Ambulatory Surgical Centers (ASCS)

  • Clinics

  • Diagnostic Centers

• • Others